{"id":"W1993873445","doi":"10.1038/bjc.2013.553","title":"A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Cancer Institute, University of Pittsburgh; Hospital for Sick Children; V Foundation for Cancer Research","keywords":"Medicine; Bevacizumab; Cyclophosphamide; Imatinib; Nausea; Internal medicine; Oncology; Gastroenterology; Chemotherapy; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001725013,0.001372133,0.001575924,0.0004565818,0.0003155623,0.0006265628,0.0006960632,0.0009271147,0.003467656],"category_scores_gemma":[0.0009788385,0.0004457261,0.0007225014,0.000341354,0.0006347691,0.0005469098,0.0003356471,0.00246344,0.0005809427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008396079,"about_ca_system_score_gemma":0.001350814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000504847,"about_ca_topic_score_gemma":0.001687231,"domain_scores_codex":[0.9994401,0.0003033638,0.00002746377,0.00009192742,0.00005979288,0.00007718081],"domain_scores_gemma":[0.9991517,0.0001643244,0.0002521484,0.00003503541,0.00004075014,0.0003560117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7838263,0.03881057,0.006405331,0.0014034,0.001348118,0.0003192401,0.0002054977,0.003107924,0.04020068,0.0002708259,0.005784123,0.118318],"study_design_scores_gemma":[0.6713076,0.3141014,0.007218038,0.00005055083,0.0003743606,0.0003937757,0.00002232381,0.001525521,0.002734964,0.000137083,0.002111284,0.00002312021],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914833,0.003888129,0.0004894275,0.0005544198,0.0001006064,0.001765247,0.0004673153,0.00006800827,0.001183539],"genre_scores_gemma":[0.9877862,0.002376522,0.00230287,0.0009086526,0.0002363793,0.003098517,0.001669641,0.00002424673,0.001597033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003467656,"threshold_uncertainty_score":0.01160043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01080242609097095,"score_gpt":0.3192174602099995,"score_spread":0.3084150341190286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}